Skip to content
Catalyst

knowcompoundsa neolactoside III(3)-alpha-Fuc-nLc4Cer(d18:1(4E))

Specimen compound organic compound

a neolactoside III(3)-alpha-Fuc-nLc4Cer(d18:1(4E))

A branched glycopentaosylceramide having α-L-fucosyl-(1→3)-[β-D-galactosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucose as the glycopentaosyl portion.”

Formula
C51H89N2O27R
Molar mass
1162.25 g/mol

01 · identity

Structure

fig. 1a neolactoside III(3)-alpha-Fuc-nLc4Cer(d18:1(4E)) · 2D structure · ChEBI’s SMILES
Charge
0
SMILES
*C(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@H](O[C@@H]4O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]4O)[C@H]3NC(C)=O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)/C=C/CCCCCCCCCCCCC

02 · documented · reference

Interactions

Documented interactions
None reported

Pairs that share biology

What the reference databases state

Reactions · Rhea
1reaction

03 · the record

Other names

15 names

alpha-L-Fuc-(1->3)-[beta-D-Gal-(1->4)]-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(11')-Cer · alpha-L-fucosyl-(1->3)-[beta-D-galactosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(11')-ceramide · alpha-L-fucosyl-(1->3)-[beta-D-galactosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(11')-N-acylsphing-4-enine · Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer · LNFP-III · LNFPIII · N-[(2S,3R,4E)-1-{[6-deoxy-alpha-L-galactopyranosyl-(1->3)-[beta-D-galactopyranosyl-(1->4)]-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]alkanamide · N-[(2S,3R,4E)-1-{[6-deoxy-α-L-galactopyranosyl-(1→3)-[β-D-galactopyranosyl-(1→4)]-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→3)-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]alkanamide · N-[(2S,3R,4E)-1-{[alpha-L-fucosyl-(1->3)-[beta-D-galactosyl-(1->4)]-2-acetamido-2-deoxy-beta-D-glucosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]alkanamide · N-[(2S,3R,4E)-1-{[α-L-fucosyl-(1→3)-[β-D-galactosyl-(1→4)]-2-acetamido-2-deoxy-β-D-glucosyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]alkanamide · X-hapten, SSEA-1, Lex-5 · α-L-Fuc-(1→3)-[β-D-Gal-(1→4)]-β-D-GlcNAc-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer · α-L-fucosyl-(1→3)-[β-D-galactosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide

systematic · N-[(2S,3R,4E)-1-{[alpha-L-fucopyranosyl-(1->3)-[beta-D-galactopyranosyl-(1->4)]-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]alkanamide

systematic · N-[(2S,3R,4E)-1-{[α-L-fucopyranosyl-(1→3)-[β-D-galactopyranosyl-(1→4)]-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→3)-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]alkanamide